| User's Publication |
|
20478
Xu J, Zhou Y, Yang J, Gu Y, Zhang E, Yuan W, Wang C, Jin G, Ma H, Hu Z.
Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
Gene
2022
146115
PubMed ID: 34902508
DOI: 10.1016/j.gene.2021.146115
|
|
20571
Fu L, Yonemura A, Yasuda-Yoshihara N, Umemoto T, Zhang J, Yasuda T, Uchihara T, Akiyama T, Kitamura F, Yamashita K, Okamoto Y, Bu L, Wei F, Hu X, Liu Y, Ajani JA, Tan P, Baba H, Ishimoto T.
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
Gastric Cancer
2022
PubMed ID: 35166958
DOI: 10.1007/s10120-022-01283-z
|
|
20593
Ebert K, Haffner I, Zwingenberger G, Keller S, Raimúndez E, Geffers R, Wirtz R, Barbaria E, Hollerieth V, Arnold R, Walch A, Hasenauer J, Maier D, Lordick F, Luber B.
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.
BMC Cancer
2022
22(1):254
PubMed ID: 35264144
DOI: 10.1186/s12885-022-09335-4
|
|
20664
Han Y, Dong Q, Liu T, Chen X, Yu C, Zhang Y.
The novel mechanism of Med12-mediated drug resistance in a TGFBR2-independent manner.
Biochem Biophys Res Commun
2022
610:1-7
PubMed ID: 35461070
DOI: 10.1016/j.bbrc.2022.04.029
|
|
17107
Liu B, Katoh H, Komura D, Yamamoto A, Ochi M, Onoyama T, Abe H, Ushiku T, Seto Y, Suo J, Ishikawa S.
Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers
J Pathol
2022
2022 Jun 13
PubMed ID: 35696251
DOI: 10.1002/path.5980
|
|
20887
Wang Y, Chen H, Liu W, Yan H, Zhang Y, Cheung AHK, Zhang J, Chen B, Liang L, Zhou Z, Wong CC, Wu WKK, Chan MWY, Cheng ASL, Ma BBY, Yu J, Lo KW, To KF, Kang W.
MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Theranostics
2022
12(15):6509-6526
PubMed ID: 36185598
DOI: 10.7150/thno.75431
|
|
13337
Kim S, Ahn JM, Bae WJ, Han JH, Lee D.
Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer.
Gastric Cancer
2021
24(3):577-588
PubMed ID: 33164142
DOI: 10.1007/s10120-020-01139-4
|
|
13647
Hikita K, Yamakage Y, Okunaga H, Motoyama Y, Matsuyama H, Matsuoka K, Murata T, Nakayoshi T, Oda A, Kato K, Tanaka H, Asao N, Dan S, Kaneda N.
(S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells
Bioorg Med Chem
2021
30:115904.
PubMed ID: 33341500
DOI: 10.1016/j.bmc.2020.115904
|
|
14347
Matsumura S, Nakamori M, Tsuji T, Kato T, Nakamura M, Ojima T, Fukuhara H, Ino Y, Todo T, Yamaue H.
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
Oncotarget
2021
12(4):344-354
PubMed ID: 33659045
DOI: 10.18632/oncotarget.27873
|
|
20415
Ikari N, Serizawa A, Tanji E, Yamamoto M, Furukawa T.
Analysis of RHOA mutations and their significance in the proliferation and transcriptome of digestive tract cancer cells.
Oncol Lett
2021
22(4):735
PubMed ID: 34466148
DOI: 10.3892/ol.2021.12996
|
|
11819
Moro H, Hattori N, Nakamura Y, Kimura K, Imai T, Maeda M, Yashiro M, Ushijima T.
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.
Gastric Cancer
2020
23(1):105-115
PubMed ID: 31555951
DOI: 10.1007/s10120-019-01010-1
|
|
12039
Kim JH, Park S, Lim SM, Eom HJ, Balch C, Lee J, Kim GJ, Jeong JH, Nam S, Kim YH.
Rational design of small molecule RHOA inhibitors for gastric cancer.
Pharmacogenomics J.
2020
PubMed ID: 32015453
DOI: 10.1038/s41397-020-0153-6
|
|
13242
Uejima C, Morimoto M, Yamamoto M, Hara K, Miyauchi W, Sugezawa K, Tada Y, Tanio A, Kihara K, Matsunaga T, Tokuyasu N, Sakamoto T, Honjo S, Umekita Y, Fujiwara Y.
Prognostic Significance of TYRO3 Receptor Tyrosine Kinase Expression in Gastric Cancer.
Anticancer Res
2020
40(10):5593-5600
PubMed ID: 32988883
DOI: 10.21873/anticanres.14572
|
|
13315
Ebert K, Zwingenberger G, Barbaria E, Keller S, Heck C, Arnold R, Hollerieth V, Mattes J, Geffers R, Raimúndez E, Hasenauer J, Luber B.
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
BMC Cancer
2020
PubMed ID: 33115415
DOI: 10.1186/s12885-020-07540-7
|
|
13600
Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers
Biochem Biophys Res Commun
2020
529(3):582-589.
PubMed ID: 32736677
DOI: 10.1016/j.bbrc.2020.05.168
|
|
11505
Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K.
Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression.
Biochem Biophys Rep
2019
18:100632
PubMed ID: 30993217
DOI: 10.1016/j.bbrep.2019.100632
|
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
DOI: 10.1038/s41586-019-1103-9
|
|
11499
S Zhang et al
Sensitization of Gastric Cancer Cells to Irinotecan by p53 Activation
BPB Reports
2019
2,130-133
|
|
10766
Devanand P, Oya Y, Sundaramoorthy S, Song KY, Watanabe T, Kobayashi Y, Shimizu Y, Hong SA, Suganuma M, Lim IK.
Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression.
Exp. Mol. Med.
2018
50:e449
PubMed ID: 29472702
DOI: 10.1038/emm.2017.281
|
|
11231
Wang Z, Qu H, Gong W, Liu A.
Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
IUBMB Life
2018
PubMed ID: 30281914
DOI: 10.1002/iub.1934
|
|
11282
Sekino N, Kano M, Matsumoto Y, Sakata H, Murakami K, Toyozumi T, Otsuka R, Yokoyama M, Shiraishi T, Okada K, Kamata T, Ryuzaki T, Matsubara H.
The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.
Anticancer Res.
2018
PubMed ID: 30396946
DOI: 10.21873/anticanres.12982
|
|
11338
Oku T, Shimada K, Kenmotsu H, Ando Y, Kurisaka C, Sano R, Tsuiji M, Hasegawa S, Fukui T, Tsuji T.
Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-α: A Role in the Invasion of Gastric Carcinoma Cells.
Int J Mol Sci
2018
PubMed ID: 30544870
DOI: 10.3390/ijms19123961
|
|
4425
Curcumin inhibition of the effects of Tip α induced cytokine expression in gastric cancer patients
PharmaNutrition
2018
6,100-106
DOI: 10.1016/j.phanu.2018.05.003
|
|
4190
Kurata A, Yamada M, Ohno SI, Inoue S, Hashimoto H, Fujita K, Takanashi M, Kuroda M.
Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Oncol. Rep.
2018
PubMed ID: 29138864
DOI: 10.3892/or.2017.6093
|
|
4300
Keller S, Zwingenberger G, Ebert K, Hasenauer J, Wasmuth J, Maier D, Haffner I, Schierle K, Weirich G, Luber B.
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
Mol Oncol
2018
PubMed ID: 29325228
DOI: 10.1002/1878-0261.12170
|
|
5801
Jiao S, Guan J, Chen M, Wang W, Li C, Wang Y, Cheng Y, Zhou Z.
Targeting IRF3 as a YAP agonist therapy against gastric cancer.
J Exp Med
2018
215(2):699-718
PubMed ID: 29339449
DOI: 10.1084/jem.20171116
|
|
13126
Gaowa S, Futamura M, Tsuneki M, Kamino H, Tajima JY, Mori R, Arakawa H, Yoshida K.
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Cancer Sci
2018
PubMed ID: 30290054
DOI: 10.1111/cas.13824
|
|
9788
Deguchi Y, Okabe H, Oshima N, Hisamori S, Minamiguchi S, Muto M, Sakai Y.
PTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma.
Gastric Cancer
2017
20:416-427
PubMed ID: 27517839
DOI: 10.1007/s10120-016-0627-z
|
|
10098
Ito C, Nishizuka SS, Ishida K, Uesugi N, Sugai T, Tamura G, Koeda K, Sasaki A.
Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer.
J. Surg. Res.
2017
212:195-204
PubMed ID: 28550907
DOI: 10.1016/j.jss.2017.01.018
|
|
4550
Segatto M, Fittipaldi R, Pin F, Sartori R, Dae Ko K, Zare H, Fenizia C, Zanchettin G, Pierobon ES, Hatakeyama S, Sperti C, Merigliano S, Sandri M, Filippakopoulos P, Costelli P, Sartorelli V, Caretti G.
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.
Nat Commun
2017
8(1):1707
PubMed ID: 29167426
DOI: 10.1038/s41467-017-01645-7
|
|
5804
Authors: Takashi Okuda Tomohiko Taki Kazuhiro Nishida Yoshiaki Chinen Hisao Nagoshi Chouhei Sakakura Masafumi Taniwaki
Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26
Oncology Letters
2017
13(1):215-221
PubMed ID: 28123544
DOI: 10.3892/ol.2016.5386
|
|
14615
Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, Hu Q, Iguchi T, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Saeki H, Oki E, Maehara Y, Suzuki A, Mimori K.
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Oncotarget
2017
8(64):107666-107677
PubMed ID: 29296196
DOI: 10.18632/oncotarget.22587
|
|
14737
Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, Okuyama K, Kitagawa H, Tanaka T, Hiraki M, Yanagihara K, Noshiro H.
Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines
Sci Rep
2017
7(1):11127
PubMed ID: 28894280
DOI: 10.1038/s41598-017-11769-x
|
|
9670
Nukuda A, Endoh H, Yasuda M, Mizutani T, Kawabata K, Haga H.
Role of ATF5 in the invasive potential of diverse human cancer cell lines.
Biochem. Biophys. Res. Commun.
2016
474:509-514
PubMed ID: 27125458
DOI: 10.1016/j.bbrc.2016.04.131
|
|
9731
Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O.
Establishment of anti-mesothelioma monoclonal antibodies.
BMC Res Notes
2016
9:324
PubMed ID: 27342200
DOI: 10.1186/s13104-016-2128-x
|
|
12951
Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M, Noshiro H.
Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer
Oncol Lett
2016
11(2):1026-1034.
PubMed ID: 26893686
DOI: 10.3892/ol.2015.4011
|
|
5818
Feng Y et al
Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
Cancer Sci
2015
106(10):1313-22
PubMed ID: 26211905
DOI: 10.1111/cas.12754
|
|
14387
Shinozaki-Ushiku A, Kunita A, Isogai M, Hibiya T, Ushiku T, Takada K, Fukayama M.
Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis
J Virol
2015
89(10):5581-91
PubMed ID: 25740983
DOI: 10.1128/JVI.03639-14
|
|
14977
Suenaga M, Yamada S, Fuchs BC, Fujii T, Kanda M, Tanaka C, Kobayashi D, Fujiwara M, Tanabe KK, Kodera Y.
CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence
J Surg Oncol
2015
112(6):622-8
PubMed ID: 26416034
DOI: 10.1002/jso.24056
|
|
15037
Toiyama Y, Tanaka K, Kitajima T, Shimura T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, Ohi M, Inoue Y, Mohri Y, Goel A, Kusunoki M.
Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients
Carcinogenesis
2015
36(12):1474-83
PubMed ID: 26420253
DOI: 10.1093/carcin/bgv139
|
|
5827
Ito T, Kajino K, Abe M, Sato K, Maekawa H, Sakurada M, Orita H, Wada R, Kajiyama Y, Hino O.
ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.
Oncol Rep
2014
31(1):27-33
PubMed ID: 24146039
DOI: 10.3892/or.2013.2803
|
|
5828
Watanabe T, Takahashi A, Suzuki K, Kurusu-Kanno M, Yamaguchi K, Fujiki H, Suganuma M.
Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein of Helicobacter pylori.
Int J Cancer
2014
134(10):2373-82
PubMed ID: 24249671
DOI: 10.1002/ijc.28582
|
|
6398
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S
Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Biochem Biophys Res Commun
2014
450(1):545-9
PubMed ID: 24924629
DOI: 10.1016/j.bbrc.2014.06.007
|
|
5845
Konno-Shimizu M1, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K.
Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
PLoS One
2013
8(2):e56766
PubMed ID: 23451082
DOI: 10.1371/journal.pone.0056766
|
|
9102
Toshiaki Tsuji, Mikihito Nakamori, Makoto Iwahashi, Masaki Nakamura, Toshiyasu Ojima, Takeshi Iida, Masahiro Katsuda, Keiji Hayata, Yasushi Ino, Tomoki Todo, Hiroki Yamaue
An Armed Oncolytic Herpes Simplex Virus Expressing thrombospondin-1 Has an Enhanced in Vivo Antitumor Effect Against Human Gastric Cancer
Int J Cancer
2013
132 (2), 485-94
PubMed ID: 22729516
DOI: 10.1002/ijc.27681
|
|
7628
Kamoshida G, Matsuda A, Sekine W, Mizuno H, Oku T, Itoh S, Irimura T, Tsuji T.
Monocyte differentiation induced by co-culture with tumor cells involves RGD-dependent cell adhesion to extracellular matrix.
Cancer Lett.
2012
315:145-52
PubMed ID: 22104730
DOI: 10.1016/j.canlet.2011.09.029
|
|
5848
Kataoka Y, Mukohara T, Tomioka H, Funakoshi Y, Kiyota N, Fujiwara Y, Yashiro M, Hirakawa K, Hirai M, Minami H.
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
Invest New Drugs
2012
30(4):1352-60
PubMed ID: 21655918
DOI: 10.1007/s10637-011-9699-0
|
|
5850
Miyato H, Tsuno NH, Kitayama J.
Semaphorin 3C is involved in the progression of gastric cancer.
Cancer Sci
2012
103(11):1961-6
PubMed ID: 22924992
DOI: 10.1111/cas.12003
|
|
5852
Tomioka H, Mukohara T, Kataoka Y, Ekyalongo RC, Funakoshi Y, Imai Y, Kiyota N, Fujiwara Y, Minami H.
Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
Int J Oncol
2012
41(2):551-8
PubMed ID: 22614071
DOI: 10.3892/ijo.2012.1485
|
|
7876
Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.
Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Ann. Surg. Oncol.
2011
18:3013-9
PubMed ID: 21409489
DOI: 10.1245/s10434-011-1636-0
|
|
8253
Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M, Hirata Y, Maeda S, Koike K, Omata M.
Reduced expression of RAS protein activator like-1 in gastric cancer.
Int. J. Cancer
2011
128:1293-302
PubMed ID: 20473946
DOI: 10.1002/ijc.25459
|
|
5865
Nakata W, Hayakawa Y, Nakagawa H, Sakamoto K, Kinoshita H, Takahashi R, Hirata Y, Maeda S, Koike K.
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.
Int J Oncol
2011
39(6):1529-36
PubMed ID: 21785822
DOI: 10.3892/ijo.2011.1141
|
|
5866
Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K.
Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
Am J Pathol
2011
178(2):515-24
PubMed ID: 21281785
DOI: 10.1016/j.ajpath.2010.10.010
|
|
6115
Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, Ozaki I, Matsuhashi S.
Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Oncol Rep
2011
26(6):1385-92
PubMed ID: 21894439
DOI: 10.3892/or.2011.1450
|
|
8110
Ramachandran S, Shida D, Nagahashi M, Fang X, Milstien S, Takabe K, Spiegel S.
Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription.
FEBS Lett.
2010
584:4077-82
PubMed ID: 20804754
DOI: 10.1016/j.febslet.2010.08.035
|
|
8315
Saito Y, Sekine W, Sano R, Komatsu S, Mizuno H, Katabami K, Shimada K, Oku T, Tsuji T.
Potentiation of cell invasion and matrix metalloproteinase production by alpha3beta1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5.
Clin. Exp. Metastasis
2010
27:197-205
PubMed ID: 20352300
DOI: 10.1007/s10585-010-9314-3
|
|
5868
Tsunemi S, Nakanishi T, Fujita Y, Bouras G, Miyamoto Y, Miyamoto A, Nomura E, Takubo T, Tanigawa N.
Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Oncol Rep
2010
23(4):949-56
PubMed ID: 20204278
DOI: 10.3892/or_00000719
|
|
5877
Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.
Biol Pharm Bull
2009
32(7):1148-54
PubMed ID: 19571376
DOI: 10.1248/bpb.32.1148
|
|
5882
Shichiri M, Fukai N, Kono Y, Tanaka Y.
Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.
Cancer Res
2009
69(11):4760-8
PubMed ID: 19458074
DOI: 10.1158/0008-5472.CAN-08-3417
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
5886
Inoue M, Matsumoto S, Saito H, Tsujitani S, Ikeguchi M.
Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
Int J Cancer.
2008
123(11):2696-701
PubMed ID: 18798274
DOI: 10.1002/ijc.23867
|
|
12803
Lindén SK, Driessen KM, McGuckin MA.
Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions
Helicobacter
2007
12(4):341-53
PubMed ID: 17669108
DOI: 10.1111/j.1523-5378.2007.00509.x
|
|
16154
Higashiyama M, Ito T, Tanaka E, Shimada Y.
Prognostic significance of osteopontin expression in human gastric carcinoma
Ann Surg Oncol
2007
14(12):3419-27
PubMed ID: 17896150
DOI: 10.1245/s10434-007-9564-8
|
|
5897
Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, Ozaki M, Ito H, Ikeguchi M.
Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Oncology
2006
70(2):126-33
PubMed ID: 16645325
DOI: 10.1159/000093003
|
|
5904
Matsumoto S, Saito H, Tsujitani S, Ikeguchi M.
Allogeneic gastric cancer cell-dendritic cell hybrids induce tumor antigen (carcinoembryonic antigen) specific CD8(+) T cells.
Cancer Immunol Immunother
2006
55(2):131-9
PubMed ID: 15891883
DOI: 10.1007/s00262-005-0684-3
|
|
3167
Horie, Nobuyuki, Hirabayashi, Naomi, Takahashi, Yoshie, Miyauchi, Yuko, Taguchi, Hiroko, Takeishi, Keiichi
Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells.
Biol Pharm Bull
2005
28:574-9
PubMed ID: 15802789
DOI: 10.1248/bpb.28.574
|
|
5909
Matsui Y, Inomata M, Tojigamori M, Sonoda K, Shiraishi N, Kitano S.
Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.
Int J Oncol
2005
27(3):681-5
PubMed ID: 16077916
|
|
5912
Nakamura M, Gabazza EC, Imoto I, Yano Y, Taguchi O, Horiki N, Fukudome K, Suzuki K, Adachi Y.
Anti-inflammatory effect of activated protein C in gastric epithelial cells.
J Thromb Haemost
2005
3(12):2721-9
PubMed ID: 16246255
DOI: 10.1111/j.1538-7836.2005.01635.x
|
|
5919
Shizue Yoshioka, Shigeru Tatebe, Naruo Tokuyasu, Kenjiro Taniguchi, Yoshimi Ogami, Osamu Yamamoto, Keigo Ashida, Yoshihito Gomyo, Akira Kondo, Shunichi Tsujitani and Masahide Ikeguchi
The PI3K-Akt Pathway in SN-38-Induced Apoptosis in Human Gastric Cancer Cell Lines
Yonago Acta medica
2005
48:7–16
|
|
6449
Yamashita Y, Nishida K, Okuda T, Nomura K, Matsumoto Y, Mitsufuji S, Horiike S, Hata H, Sakakura C, Hagiwara A, Yamagishi H, Taniwaki M.
Recurrent chromosomal rearrangements at bands 8q24 and 11q13 in gastric cancer as detected by multicolor spectral karyotyping.
World J Gastroenterol
2005
11(33):5129-35
PubMed ID: 16127741
DOI: 10.3748/wjg.v11.i33.5129
|
|
12834
Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y.
Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori
Mol Biol Cell
2005
16(10):4954-66.
PubMed ID: 16030249
DOI: 10.1091/mbc.e05-05-0426
|
|
2807
Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H
Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Exp Cell Res
2004
301:168-78
PubMed ID: 15530853
DOI: 10.1016/j.yexcr.2004.08.008
|
|
5922
Meng H, Lu C, Mabuchi H, Tanigawa N.
Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Cancer Lett
2004
216(2):147-55
PubMed ID: 15533590
DOI: 10.1016/j.canlet.2003.12.020
|
|
5940
Chong JM, Sakuma K, Sudo M, Osawa T, Ohara E, Uozaki H, Shibahara J, Kuroiwa K, Tominaga S, Hippo Y, Aburatani H, Funata N, Fukayama M.
Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.
J Virol
2002
76(13):6825-31
PubMed ID: 12050395
DOI: 10.1128/jvi.76.13.6825-6831.2002
|
|
5941
Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Kashiwaba M, Oyama K, Takahashi M, Maesawa C, Saito K, Takechi T, Fukushima M.
Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
Jpn J Cancer Res
2002
93(12):1342-50
PubMed ID: 12495474
DOI: 10.1111/j.1349-7006.2002.tb01243.x
|
|
3772
Ijichi H, Ikenoue T, Kato N, Mitsuno Y, Togo G, Kato J, Kanai F, Shiratori Y, Omata M.
Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.
Biochem Biophys Res Commun
2001
289(2):350-7
PubMed ID: 11716479
DOI: 10.1006/bbrc.2001.5988
|
|
5950
Sato K, Sasaki K, Akiyama Y, Yamaguchi K.
Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines.
Cancer Lett
2001
170(2):153-9
PubMed ID: 11463493
DOI: 10.1016/s0304-3835(01)00567-5
|
|
5953
Matsumura M, Ijichi M, Shiratori Y, Togo G, Hikiba Y, Inoued K, Kohara M, Omata M.
Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use.
Hepatol Res
2001
20(1):84-96
PubMed ID: 11282488
DOI: 10.1016/s1386-6346(00)00131-5
|
|
5957
Senoo M, Tsuchiya I, Matsumura Y, Mori T, Saito Y, Kato H, Okamoto T, Habu S.
Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Br J Cancer
2001
84(9):1235-41
PubMed ID: 11336476
DOI: 10.1054/bjoc.2000.1735
|
|
5958
Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Shimomura K, Nakamura Y, Inazawa J, Abe T, Yamagishi H.
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.
Br J Cancer
2001
84(6):824-31
PubMed ID: 11259099
DOI: 10.1054/bjoc.2000.1684
|
|
15111
Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, Sasaki K, Narimatsu H.
Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids
J Biol Chem
2001
276(25):22032-40
PubMed ID: 11283017
DOI: 10.1074/jbc.M011369200
|
|
16965
Ueda K, Iwahashi M, Nakamori M, Nakamura M, Matsuura I, Yamaue H, Tanimura H.
Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model
Cancer Res
2001
6158-62
PubMed ID: 11507067
|
|
2194
Nishizuka S, Tamura G, Maesawa C, Sakata K, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R
Analysis of the DPC4 gene in gastric carcinoma
Jpn J Cancer Res
1997
88:335-339
PubMed ID: 9197522
DOI: 10.1111/j.1349-7006.1997.tb00385.x
|
|
5973
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Genes Chromosomes Cancer
1997
20(1):98-102
PubMed ID: 9290961
|
Back
Top
CELL BANK Website